4
Changes in Ownership
AIM ImmunoTech Inc. Filed Acc 0001613377-16-000029
Options or other derivatives
- CEO acquired 14,167 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Pascale Adam · CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-06-30 | Grant or award : show line 1 in the form Incentive Rights | +14,167 | $0.12 | $1,700 | 14,167 | D |
Loading xslF345X03/primary_doc.xml…